Waisman Biomanufacturing Contract Manufacturing & Development (CDMO) Profile
Waisman Biomanufacturing, strategically part of the University of Wisconsin-Madison, has extensive experience in manufacturing a wide range of biologics for human clinical trials including plasmid DNA, cell therapeutics, viral vectors, vaccines, and recombinant proteins for internal and external biotech, non-profit, and academic partners.
CDMO Services:
Biologics; Cell & Gene Therapy Drug Substance Manufacturing (API); Drug Product Formulation (FDF); Analytical Development
Year Founded: 1848
Head Office: Madison, United States
Number of Facilities: 1
Facility locations: North America
Website: Visit the Waisman Biomanufacturing website
Linkedin: Connect on Linkedin
Current Capacity: Waisman supports Phase 1 and 2 manufacturing and has capacity for new business.
Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing. 
Stay ahead of trends and best practices
